CXCR2
C-X-C chemokine receptor type 2
Also known as: CD182, CMKAR2, CXCR2_HUMAN, IL8RB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25025
- Gene
- CXCR2
- Ensembl
- ENSG00000180871
- Chromosome
- 2
- Canonical length
- 360 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle
OverviewNCBI Gene
The protein encoded by this gene is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth. This receptor mediates neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal microvascular endothelial cells are found to be mediated by this receptor. Knockout studies in mice suggested that this receptor controls the positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. This gene, IL8RA, a gene encoding another high affinity IL8 receptor, as well as IL8RBP, a pseudogene of IL8RB, form a gene cluster in a region mapped to chromosome 2q33-q36. Alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
360 residues, UniProt reviewed canonical sequence.
>P25025|CXCR2
1 MEDFNMESDS FEDFWKGEDL SNYSYSSTLP PFLLDAAPCE PESLEINKYF VVIIYALVFL
61 LSLLGNSLVM LVILYSRVGR SVTDVYLLNL ALADLLFALT LPIWAASKVN GWIFGTFLCK
121 VVSLLKEVNF YSGILLLACI SVDRYLAIVH ATRTLTQKRY LVKFICLSIW GLSLLLALPV
181 LLFRRTVYSS NVSPACYEDM GNNTANWRML LRILPQSFGF IVPLLIMLFC YGFTLRTLFK
241 AHMGQKHRAM RVIFAVVLIF LLCWLPYNLV LLADTLMRTQ VIQETCERRN HIDRALDATE
301 ILGILHSCLN PLIYAFIGQK FRHGLLKILA IHGLISKDSL PKDSRPSFVG SSSGHTSTTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CXCR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- spleen: 41 nTPM
- appendix: 39 nTPM
- esophagus: 26 nTPM
- adipose tissue: 13 nTPM
- tongue: 11 nTPM
- gallbladder: 7.4 nTPM
Single-cell type
- neutrophils: 1,412 nCPM
- esophageal apical cells: 101 nCPM
- neutrophil progenitors: 46 nCPM
- esophageal suprabasal cells: 45 nCPM
- nk-cells: 22 nCPM
- prostatic hillock cells: 11 nCPM
Immune cell
- neutrophil: 3,298 nTPM
- basophil: 64 nTPM
- eosinophil: 51 nTPM
- classical monocyte: 30 nTPM
- gdT-cell: 29 nTPM
- plasmacytoid DC: 25 nTPM
Brain region
- cerebral cortex: 6.1 nTPM
- pons: 3.8 nTPM
- basal ganglia: 2.1 nTPM
- thalamus: 2 nTPM
- medulla oblongata: 1.9 nTPM
- white matter: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CXCR2.
Disease | AllUniProt
Conditions CXCR2 is implicated in, by any mechanism.
- WHIM syndrome 2 (WHIMS2) MIM:619407
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 246 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- WHIM syndrome 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-mediated signaling
- cell surface receptor signaling pathway
- cellular defense response
- chemotaxis
- dendritic cell chemotaxis
- immune response
- inflammatory response
- negative regulation of apoptotic process
- neutrophil activation
- neutrophil chemotaxis
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of cell population proliferation
- positive regulation of cytosolic calcium ion concentration
- receptor internalization
- signal transduction
- interleukin-8-mediated signaling pathway
Molecular functions
- C-C chemokine binding
- C-C chemokine receptor activity
- C-X-C chemokine receptor activity
- G protein-coupled receptor activity
- interleukin-8 binding
- interleukin-8 receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CXCR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- GNAI2
- IL8
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CXCR2 as an antibody target. Whether an autoantibody or antibody against CXCR2 could matter depends on whether native CXCR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CXCR2 is annotated at the cell surface, where native CXCR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CXCR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...